As of 2025-03-20, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is 0.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is -52.64 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -59.15 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.7x - 8.8x | 7.0x |
| Forward P/E multiples | 7.0x - 8.9x | 8.5x |
| Fair Price | (3.30) - (4.70) | (3.88) |
| Upside | -366.9% - -480.4% | -413.9% |
| Date | EV/EBITDA |
| 2025-03-19 | 1.10 |
| 2025-03-18 | 1.09 |
| 2025-03-17 | 1.17 |
| 2025-03-14 | 1.11 |
| 2025-03-13 | 1.09 |
| 2025-03-12 | 1.11 |
| 2025-03-11 | 1.12 |
| 2025-03-10 | 1.12 |
| 2025-03-07 | 1.08 |
| 2025-03-06 | 1.14 |
| 2025-03-05 | 1.06 |
| 2025-03-04 | 1.06 |
| 2025-03-03 | 0.94 |
| 2025-02-28 | 1.01 |
| 2025-02-27 | 0.92 |
| 2025-02-26 | 0.86 |
| 2025-02-25 | 0.84 |
| 2025-02-24 | 0.78 |
| 2025-02-21 | 0.78 |
| 2025-02-20 | 0.77 |
| 2025-02-19 | 0.74 |
| 2025-02-18 | 0.73 |
| 2025-02-17 | 0.75 |
| 2025-02-14 | 0.73 |
| 2025-02-13 | 0.76 |
| 2025-02-12 | 0.77 |
| 2025-02-11 | 0.76 |
| 2025-02-10 | 0.77 |
| 2025-02-07 | 0.72 |
| 2025-02-06 | 0.70 |
| 2025-02-05 | 0.72 |
| 2025-02-04 | 0.77 |
| 2025-02-03 | 0.78 |
| 2025-01-31 | 0.73 |
| 2025-01-30 | 0.76 |
| 2025-01-29 | 0.76 |
| 2025-01-28 | 0.77 |
| 2025-01-27 | 0.74 |
| 2025-01-24 | 0.70 |
| 2025-01-23 | 0.73 |
| 2025-01-22 | 0.77 |
| 2025-01-21 | 0.77 |
| 2025-01-20 | 0.76 |
| 2025-01-17 | 0.73 |
| 2025-01-16 | 0.66 |
| 2025-01-15 | 0.60 |
| 2025-01-14 | 0.55 |
| 2025-01-13 | 0.49 |
| 2025-01-10 | 0.43 |
| 2025-01-09 | 0.45 |